EYE
Nova Eye Medical Ltd
Healthcare Equipment and Supplies
·
Healthcare
1
comment
1
fund manager
past 90 days
About Nova Eye Medical Ltd
Nova Eye Medical Ltd. develops ophthalmic treatment technologies across three segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers a catheter device that dilates ocular structures affected by glaucoma. The 2RT segment includes a patent-protected technology with a recurring per-use fee model. The Lasers and Ultrasounds segment covers Ellex brand lasers, including Ellex Tango and Ellex Tango Reflex glaucoma lasers. Founded in 1985 by Giuseppe Canala and Victor Previn, the company is headquartered in Kent Town, Australia.
Commentary Volume
1
Comments
1
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
​Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
Fund managers
1 manager
First covered
31 Jan 2026
Last updated
31 Jan 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Nova Eye Medical Ltd (ASX:EYE)
Frequently asked questions
Who is investing in Nova Eye Medical Ltd (ASX:EYE)?
Fund managers including Merewether Capital have invested in Nova Eye Medical Ltd (ASX:EYE).
What is the short interest in Nova Eye Medical Ltd (ASX:EYE)?
According to ASIC filings, there is negligible or no short interest in Nova Eye Medical Ltd (ASX:EYE).
What does Nova Eye Medical Ltd (ASX:EYE) do?
Nova Eye Medical Ltd. develops ophthalmic treatment technologies across three segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers a catheter device that dilates ocular structures affected by glaucoma. The 2RT segment includes a patent-protected technology with a recurring per-use fee model. The Lasers and Ultrasounds segment covers Ellex brand lasers, including Ellex Tango and Ellex Tango Reflex glaucoma lasers. Founded in 1985 by Giuseppe Canala and Victor Previn, the company is headquartered in Kent Town, Australia.
Loading...